Highlights

  • FY26 Revenue was $19.8M, with gross Margin maintained at 75%.
  • European revenue reached $12.9M while North American sales were $2.2M.
  • CleanSpace AGILE obtained certifications in Europe and Australia and New Zealand during 2026.
  • Cash at bank stood at $10.1M at the end of FY26.
  • Product development and regional sales execution remain important operational themes.

CleanSpace Holdings Limited (ASX:CSX) designs and manufactures wearable powered air-purifying respirators for industrial and healthcare environments. Its respiratory protection range serves workplaces where airborne hazards require specialised equipment. During FY26, the company reported broadly unchanged group revenue, contrasting regional sales trends and the certification of its CleanSpace AGILE product.

FY26 Revenue and Regional Sales

CleanSpace Holdings (ASX:CSX) reported revenue of $19.8M for the year ended 30 June 2026, an increase of 0.3%. Gross margin was 75%, unchanged from FY25. The figures point to stable aggregate sales despite different conditions across the company’s operating regions.

Europe contributed $12.9M in FY26 revenue, increasing 8%, with France identified as an important source of activity. North American revenue was $2.2M, declining 29%, while Asia-Pacific and the rest of the world contributed $4.7M, down 0.2%. The regional spread shows how geographic demand, distribution development and regulatory conditions shaped the year’s results.

For ASX:CSX, the variation matters because the Business sells through multiple markets with different procurement requirements and exposure standards. Changes in customer ordering patterns can affect reported revenue even while product development continues.

CleanSpace AGILE Certification and Product Range

During June 2026, CleanSpace AGILE achieved certification in Europe and subsequently in Australia and New Zealand. The product is a loose-fitting powered air-purifying respirator incorporating the company’s AirSensit technology. Its design adds another option alongside products such as CleanSpace WORK, CST PRO and HALO, which address different industrial and healthcare applications.

CleanSpace Holdings (ASX:CSX) identifies respiratory safety, ease of use and wearable design as central to its product approach. The certification milestones relate to specific markets and product requirements; they should not be interpreted as universal approval across every Jurisdiction or workplace application.

Cash Position and FY26 Earnings

At the end of FY26, CleanSpace reported $10.1M in cash at bank, compared with $10.5M for FY25. Reported EBITDA was $1.5M, compared with a loss of $0.4M, and included the remeasurement of the NSW Health loan. This accounting item is relevant when interpreting the EBITDA movement and distinguishing it from recurring operating performance.

CleanSpace Holdings (ASX:CSX) also described Investment in research, sales capability and Marketing during FY26. These activities support product development and customer coverage but require ongoing expenditure. The relationship between sales conversion, operating costs and cash generation remains important to the company’s financial reporting.

Operational Factors Across Key Markets

Management attributed parts of FY26 regional performance to regulatory uncertainty in North America and changing safety requirements in industrial markets. In Asia-Pacific, conditions affecting an Indonesian Mining operation also weighed on activity. In Europe, Demand for established respirator ranges provided a counterweight.

For ASX:CSX, distributor engagement and customer adoption of certified equipment are commercially relevant factors. Workplace respiratory requirements differ across industries, meaning procurement decisions can depend on application-specific certification, fit-testing rules, Training and equipment maintenance.

Key Insights

CleanSpace’s FY26 results combine largely unchanged group revenue with notable differences between Europe and North America. The AGILE certifications extend its available respiratory protection range, while its year-end cash position and reported EBITDA provide context for operating capacity. For CleanSpace Holdings (ASX:CSX), subsequent financial disclosures can show how product adoption and regional demand translate into sales and operating results.